Bill Search

  • Introduced
    Feb 03, 2025
  • Passed House
    Mar 03, 2025
  • Passed Senate
  • Signed into Law
HB 1416
Oklahoma House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Last Action See all actions
Senate • Apr 01, 2025: Second Reading referred to Health and Human Services Committee then to Appropriations Committee
Latest Bill Text See all bill texts

Summary/Bill Text

Comments on HB 1416

Tweets

Whip Lists

Sponsors
Actions
  • Apr 01, 2025 | Senate
    • Second Reading referred to Health and Human Services Committee then to Appropriations Committee
  • Mar 04, 2025 | Senate
    • First Reading
  • Mar 04, 2025 | House
    • Engrossed, signed, to Senate
  • Mar 03, 2025 | House
    • General Order
    • Coauthored by Representative(s) Fugate
    • Amended
    • Title stricken
    • Third Reading, Measure passed: Ayes: 90 Nays: 7
    • Referred for engrossment
  • Feb 26, 2025 | House
    • CR; Do Pass, amended by committee substitute Health and Human Services Oversight Committee
  • Feb 05, 2025 | House
    • Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
    • Authored by Senator Rosino (principal Senate author)
  • Feb 04, 2025 | House
    • Second Reading referred to Health and Human Services Oversight
    • Referred to Public Health
  • Feb 03, 2025 | House
    • First Reading
    • Authored by Representative West (Josh)